c-Jun overexpression in CAR T cells induces exhaustion resistance.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31802004.
- Also identified by DOI 10.1038/s41586-019-1805-z and PMC identifier 6944329.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chimeric antigen receptor (CAR) T cells mediate anti-tumour effects in a small subset of patients with cancer<sup>1-3</sup>, but dysfunction due to T cell exhaustion is an important barrier to progress<sup>4-6</sup>. To investigate the biology of exhaustion in human T cells expressing CAR receptors, we used a model system with a tonically signaling CAR, which induces hallmark features of exhaustion<sup>6</sup>. Exhaustion was associated with a profound defect in the production of IL-2, along with increased chromatin accessibility of AP-1 transcription factor motifs and overexpression of the bZIP and IRF transcription factors that have been implicated in mediating dysfunction in exhausted T cells<sup>7-10</sup>. Here we show that CAR T cells engineered to overexpress the canonical AP-1 factor c-Jun have enhanced expansion potential, increased functional capacity, diminished terminal differentiation and improved anti-tumour potency in five different mouse tumour models in vivo. We conclude that a functional deficiency in c-Jun mediates dysfunction in exhausted human T cells, and that engineering CAR T cells to overexpress c-Jun renders them resistant to exhaustion, thereby addressing a major barrier to progress for this emerging class of therapeutic agents.
Medical subject headings
- Proto-Oncogene Proteins c-jun
- Receptors, Antigen, T-Cell